Mastectomy News and Research

RSS

Mastectomy is surgery to remove the breast (or as much of the breast tissue as possible).

Lymph node radiotherapy well-tolerated after mastectomy or breast conserving surgery

In patients with early breast cancer, giving radiotherapy to the lymph nodes located behind the breast bone and above the collar bone is well-tolerated, after mastectomy or breast conserving surgery, a radiation oncologist will tell delegates at the seventh European Breast Cancer Conference (EBCC7) today (Saturday 27 March).

27 Mar 2010

Studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mutations

Two studies to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday) and tomorrow (Saturday), shed light on the treatment options facing women carrying the BRCA1 and BRCA2 genetic mutations which predispose them to breast cancer.

27 Mar 2010

Genome sequencing of tumors biopsied from women with invasive breast cancer

Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.

27 Mar 2010

Study finds 15-year outcomes of BCT and mastectomy similar

26 Mar 2010

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research.

26 Mar 2010

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.

23 Mar 2010

Skin sparing mastectomy procedures under-utilized in the U.S.

Joel A. Aronowitz, M.D., founder of the Breast Preservation Foundation and Division Clinical Chief of Plastic and Reconstructive Surgery at Cedars-Sinai Medical Center, recently led a group in Washington, D.C., to educate legislators and healthcare policy staff about the under-utilization of skin sparing mastectomy procedures in the U.S.

23 Mar 2010

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange, workflow management services and telehealth solutions, today announced that Elmora Healthcare, a supplier of home medical equipment, medical supplies and care services, selected Authentidate's Inscrybe® Healthcare web-based service to expedite processing of patient care orders with referring physicians.

16 Mar 2010

Liberator Medical Holdings closes private placement of 4.66M common stock shares

Liberator Medical Holdings, Inc. announces today the closing of a private placement of 4,666,667 shares of its common stock for gross proceeds of $7.0 million on March 9, 2010, to a single institutional investor. Littlebanc Advisors, LLC. acted as the sole placement agent and financial advisor to the Company. Liberator's Board of Directors unanimously approved the transaction. As part of the transaction, the institutional investor has the right to add a member of its choice to Liberator Medical's Board of Directors.

11 Mar 2010

Breast cancer patients with early stage disease may not benefit from radiation after mastectomy

Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D. Anderson Cancer.

7 Mar 2010

PINC trial to test anti-malarial drug in women with DCIS

Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.

3 Mar 2010

CPM procedure may only offer survival benefit to breast cancer patients age 50 and younger

Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.

26 Feb 2010

Unique resource for families facing hereditary breast and ovarian cancer

When she was forty-two, Joi Morris learned that she has a genetic mutation on a gene known as BRCA2. This meant that her risk of getting breast cancer could be as high as 84 percent by age seventy, and that her risk for ovarian cancer was also high.

23 Feb 2010

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Stem Cell Assurance, Inc. announced today that Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network. The procedure was performed at Handal Plastic Surgery in Boca Raton, Florida in the practice's onsite accredited ambulatory surgical facility.

21 Jan 2010

More than half of women with DCIS are spared a mastectomy

Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS) are spared a mastectomy, according to latest research published today in the British Journal of Cancer.

19 Jan 2010

Liberator Medical Holdings reports record net revenues for fiscal year 2009

Liberator Medical Holdings, Inc. announced net revenues for fiscal year 2009 of $25,818,000, representing an increase of $16,268,000, or 170.3%, compared with fiscal year 2008. The increase in sales occurred in the mail order segment of its business. The increase was due to a substantial direct-response advertising campaign to obtain new mail order customers.

18 Dec 2009

Consumer Watchdog calls for preserving state authority, ban on annual benefit limits and effective rate regulation

Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.

16 Dec 2009

Additional therapy and screening may be needed for patients with mucinous breast cancer

In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound.

14 Dec 2009

Cell-enriched breast reconstruction procedure improves breast deformity in lumpectomy patients

Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched breast reconstruction achieved a high rate of patient and physician satisfaction and improvements in overall breast deformity in lumpectomy patients.

14 Dec 2009

Medifocus begins common stock trading on OTC Pink Sheets market

Medifocus, Inc., a biotechnology company focused on the commercialization of a proprietary and patented microwave focused heat system for the treatment of breast cancer is pleased to announce that the Company had begun trading its common stock on the OTC Pink Sheets market on Dec. 7, 2009.

10 Dec 2009

Mastectomy News and Research

Further Reading

Lymph node radiotherapy well-tolerated after mastectomy or breast conserving surgery

Studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mutations

Genome sequencing of tumors biopsied from women with invasive breast cancer

Study finds 15-year outcomes of BCT and mastectomy similar

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Skin sparing mastectomy procedures under-utilized in the U.S.

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Liberator Medical Holdings closes private placement of 4.66M common stock shares

Breast cancer patients with early stage disease may not benefit from radiation after mastectomy

PINC trial to test anti-malarial drug in women with DCIS

CPM procedure may only offer survival benefit to breast cancer patients age 50 and younger

Unique resource for families facing hereditary breast and ovarian cancer

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

More than half of women with DCIS are spared a mastectomy

Liberator Medical Holdings reports record net revenues for fiscal year 2009

Consumer Watchdog calls for preserving state authority, ban on annual benefit limits and effective rate regulation

Additional therapy and screening may be needed for patients with mucinous breast cancer

Cell-enriched breast reconstruction procedure improves breast deformity in lumpectomy patients

Medifocus begins common stock trading on OTC Pink Sheets market

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News